| Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate | |
| Song, Yu\'ning; Lin, Xiaoqian; Kang, Dongwei; Li, Xiao; Zhan, Peng; Liu, Xinyong; Zhang, Qingzhu | |
| 刊名 | European Journal of Medicinal Chemistry: Chimie Therapeutique
 |
| 2014 | |
| 页码 | 293-307 |
| 关键词 | CDC25 inhibitor Anticancer agents Cell cycle arrest Apoptosis Reactive oxygen species |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4796202 |
| 专题 | 山东大学 |
| 作者单位 | 1.Shandong Univ, Sch Pharmaceut Sci, Minist Educ, Dept Pharmacol,Key Lab Chem Biol, Jinan 250012 2.Shandong Univ, Sch Pharmaceut Sci |
| 推荐引用方式 GB/T 7714 | Song, Yu\'ning,Lin, Xiaoqian,Kang, Dongwei,et al. Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate[J]. European Journal of Medicinal Chemistry: Chimie Therapeutique,2014:293-307. |
| APA | Song, Yu\'ning.,Lin, Xiaoqian.,Kang, Dongwei.,Li, Xiao.,Zhan, Peng.,...&Zhang, Qingzhu.(2014).Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate.European Journal of Medicinal Chemistry: Chimie Therapeutique,293-307. |
| MLA | Song, Yu\'ning,et al."Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate".European Journal of Medicinal Chemistry: Chimie Therapeutique (2014):293-307. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论